Randomized Trial: Five Days of Treatment Not Better than Three Days for Uncomplicated Lower Urinary Tract Infection

Three versus five days of pivmecillinam for community-acquired uncomplicated lower urinary tract infection: A randomised, double-blind, placebo-controlled superiority trial – EClinicalMedicine (free)

Related Commentary on Twitter

Three versus five days of pivmecillinam for #community acquired uncomplicated lower urinary tract infection: a randomised, double-blind, placebo-controlled superiority trial @EClinicalMed @uni_copenhagen #clinicaltrials

Have a read at: https://t.co/RiOIS1686B pic.twitter.com/VUyf5jhwmh

— EClinicalMedicine – Published by The Lancet (@EClinicalMed) August 1, 2019